These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36949303)

  • 21. Update on the use of MR for assessment and diagnosis of psychiatric diseases.
    Agarwal N; Port JD; Bazzocchi M; Renshaw PF
    Radiology; 2010 Apr; 255(1):23-41. PubMed ID: 20308442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dystonia genes functionally converge in specific neurons and share neurobiology with psychiatric disorders.
    Mencacci NE; Reynolds R; Ruiz SG; Vandrovcova J; Forabosco P; Sánchez-Ferrer A; Volpato V; ; ; Weale ME; Bhatia KP; Webber C; Hardy J; Botía JA; Ryten M
    Brain; 2020 Sep; 143(9):2771-2787. PubMed ID: 32889528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease.
    Czapski GA; Strosznajder JB
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain
    Skorobogatov K; De Picker L; Verkerk R; Coppens V; Leboyer M; Müller N; Morrens M
    Front Immunol; 2021; 12():716980. PubMed ID: 34630391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Translational Research on Neuropsychiatric Disorders: Focusing on Microglia Hypothesis].
    Kato TA; Ohgidani M; Kanba S
    Brain Nerve; 2017 Sep; 69(9):1007-1015. PubMed ID: 28900063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease.
    Fuhrmann M; Bittner T; Jung CK; Burgold S; Page RM; Mitteregger G; Haass C; LaFerla FM; Kretzschmar H; Herms J
    Nat Neurosci; 2010 Apr; 13(4):411-3. PubMed ID: 20305648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease.
    Cortés N; Andrade V; Maccioni RB
    J Alzheimers Dis; 2018; 63(3):899-910. PubMed ID: 29710717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emerging tale of microglia in psychiatric disorders.
    Rahimian R; Wakid M; O'Leary LA; Mechawar N
    Neurosci Biobehav Rev; 2021 Dec; 131():1-29. PubMed ID: 34536460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suicide and Microglia: Recent Findings and Future Perspectives Based on Human Studies.
    Suzuki H; Ohgidani M; Kuwano N; Chrétien F; Lorin de la Grandmaison G; Onaya M; Tominaga I; Setoyama D; Kang D; Mimura M; Kanba S; Kato TA
    Front Cell Neurosci; 2019; 13():31. PubMed ID: 30814929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.
    Pfau ML; Ménard C; Russo SJ
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():411-428. PubMed ID: 28992428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The microglia hypothesis of psychiatric disorders].
    Monji A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Feb; 31(1):1-8. PubMed ID: 21409839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling Psychiatric Disorders through Neural Single-Cell Transcriptomics Approaches.
    Chehimi SN; Crist RC; Reiner BC
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glial Cell Abnormalities in Major Psychiatric Diseases: A Systematic Review of Postmortem Brain Studies.
    Liu SH; Du Y; Chen L; Cheng Y
    Mol Neurobiol; 2022 Mar; 59(3):1665-1692. PubMed ID: 35013935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Principles of inflammasome priming and inhibition: Implications for psychiatric disorders.
    Herman FJ; Pasinetti GM
    Brain Behav Immun; 2018 Oct; 73():66-84. PubMed ID: 29902514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population.
    Martins SS; Gorelick DA
    Drug Alcohol Depend; 2011 Dec; 119(1-2):28-36. PubMed ID: 21641123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.
    Koutsouleris N; Meisenzahl EM; Borgwardt S; Riecher-Rössler A; Frodl T; Kambeitz J; Köhler Y; Falkai P; Möller HJ; Reiser M; Davatzikos C
    Brain; 2015 Jul; 138(Pt 7):2059-73. PubMed ID: 25935725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission.
    Marinelli S; Basilico B; Marrone MC; Ragozzino D
    Semin Cell Dev Biol; 2019 Oct; 94():138-151. PubMed ID: 31112798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cannabinoid system and microglia in health and disease.
    Duffy SS; Hayes JP; Fiore NT; Moalem-Taylor G
    Neuropharmacology; 2021 Jun; 190():108555. PubMed ID: 33845074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer's disease.
    Zhang L; Xu J; Gao J; Wu Y; Yin M; Zhao W
    Rev Neurosci; 2018 Nov; 29(8):837-848. PubMed ID: 29729150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.